{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:25:46Z","timestamp":1787840746394,"version":"build-2784847793"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Epigenetic changes, including DNA methylation and histone modification, alter gene expression without the nucleotide template alterations and are associated with all stages of tumor formation and progression. Previously, we investigated the effects of DNA demethylating agents and histone deacetylase inhibitors on hepatocellular carcinoma and colon cancers. The current study aimed to investigate the effects of 5-aza-2'-deoxycytidine (5-AZA-CdR, decitabine) and valproic acid (VPA), individually as well as combined on apoptosis induction and cell growth inhibition in colon cancer HT 29 cell line.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The effect of the compounds on the cell viability was measured by MTT assay. To determine cell apoptosis, the cells were treated with 5-aza-CdR and VPA. Propidium iodide was used for staining and the cells were analyzed using flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Both agents decreased cell viability in a time and dose-dependent manner significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.002). The results of flow cytometry demonstrated that 5-aza-CdR and VPA induced apoptosis significantly as opposed to control groups. Maximal percentage of apoptotic cells was obtained after 48 h with combined treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings suggest that 5-aza-CdR and VPA can significantly inhibit cell growth and induce apoptosis in colon cancer HT 29 cell line.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_410_19","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T08:29:49Z","timestamp":1716884989000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Effects of 5-Aza-2'-Deoxycytidine and Valproic Acid on Apoptosis Induction and Cell Growth Inhibition in Colon Cancer HT 29 Cell Line"],"prefix":"10.4103","volume":"12","author":[{"given":"Masumeh","family":"Sanaei","sequence":"first","affiliation":[{"name":"Research Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Fars Province, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraidoon","family":"Kavoosi","sequence":"additional","affiliation":[{"name":"Research Center for Non-communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Fars Province, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Sahraeian","sequence":"additional","affiliation":[{"name":"Student of Research Committee, Jahrom University of Medical Sciences, Jahrom, Fars Province, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"key":"R1-20250812","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/ijms16022472","article-title":"Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer","volume":"16","author":"Ng","year":"2015","journal-title":"Int J Mol Sci"},{"key":"R2-20250812","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1742-7843.2008.00325.x","article-title":"Epigenetic changes in cancer as potential targets for prophylaxis and maintenance therapy","volume":"103","author":"Gr\u00f8nb\u00e6k","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R3-20250812","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1515\/cclm-2011-0935","article-title":"DNA methylation biomarkers and their utility for solid cancer diagnostics","volume":"50","author":"Heichman","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"R4-20250812","doi-asserted-by":"crossref","first-page":"15029","DOI":"10.3390\/ijms140715029","article-title":"DNA methylation and cancer diagnosis","volume":"14","author":"Delpu","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R5-20250812","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molonc.2007.01.001","article-title":"The role of histone deacetylases (HDACs) in human cancer","volume":"1","author":"Ropero","year":"2007","journal-title":"Mol Oncol"},{"key":"R6-20250812","first-page":"2989","article-title":"DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer","volume":"33","author":"Gnyszka","year":"2013","journal-title":"Anticancer Res"},{"key":"R7-20250812","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/15680096113139990077","article-title":"DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer","volume":"13","author":"Singh","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"R8-20250812","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/carcin\/21.3.461","article-title":"DNA methylation: Past, present and future directions","volume":"21","author":"Robertson","year":"2000","journal-title":"Carcinogenesis"},{"key":"R9-20250812","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.seminoncol.2005.07.008","article-title":"Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine)","volume":"32","author":"Momparler","year":"2005","journal-title":"Seminars in Oncology"},{"key":"R10-20250812","first-page":"1","article-title":"Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors","volume":"2011","author":"Federico","year":"2010","journal-title":"Biomed Res Int"},{"key":"R11-20250812","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: Molecular mechanisms of action","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"key":"R12-20250812","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1475-2867-6-2","article-title":"Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines","volume":"6","author":"Chavez-Blanco","year":"2006","journal-title":"Cancer Cell Int"},{"key":"R13-20250812","first-page":"12","article-title":"Comparative analysis of the effects of valproic acid and tamoxifen on proliferation, and apoptosis of human hepatocellular carcinoma WCH 17 CellLin","volume":"8","author":"Kavoosi","year":"2018","journal-title":"Iran J Ped Hematol Oncol"},{"key":"R14-20250812","doi-asserted-by":"crossref","first-page":"95","DOI":"10.31768\/2312-8852.2018.40(2):95-100","article-title":"Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro","volume":"40","author":"Sanaei","year":"2018","journal-title":"Exp Oncol"},{"key":"R15-20250812","first-page":"2507","article-title":"In vitro effect of the histone deacetylase inhibitor valproic acid on viability and apoptosis of the PLC\/PRF5 human hepatocellular carcinoma cell line","volume":"19","author":"Sanaei","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"R16-20250812","first-page":"3445","article-title":"Genistein and trichostatin A induction of estrogen receptor alpha gene expression, apoptosis and cell growth inhibition in hepatocellular carcinoma HepG 2 cells","volume":"18","author":"Sanaei","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R17-20250812","first-page":"2381","article-title":"Effects of genistein and synergistic action in combination with tamoxifen on the HepG2 human hepatocellular carcinoma cell line","volume":"18","author":"Sanaei","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"R18-20250812","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/abr.abr_53_17","article-title":"Effect of genistein and 17-\u03b2 estradiol on the viability and apoptosis of human hepatocellular carcinoma HepG2 cell line","volume":"6","author":"Sanaei","year":"2017","journal-title":"Adv Biomed Res"},{"key":"R19-20250812","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14218\/JCTH.2018.00002","article-title":"Effect of Genistein in comparison with trichostatin A on reactivation of DNMTs genes in hepatocellular carcinoma","volume":"6","author":"Sanaei","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"R20-20250812","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/ijpvm.IJPVM_249_16","article-title":"Effect of genistein on apoptosis and proliferation of hepatocellular Carcinoma Hepa1-6 Cell Line","volume":"9","author":"Sanaei","year":"2018","journal-title":"Int J Prev Med"},{"key":"R21-20250812","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1053\/j.gastro.2015.07.011","article-title":"Epigenetic alterations in colorectal cancer: Emerging biomarkers","volume":"149","author":"Okugawa","year":"2015","journal-title":"Gastroenterology"},{"key":"R22-20250812","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pharmthera.2018.02.006","article-title":"Nucleosidic DNA demethylating epigenetic drugs\u2013A comprehensive review from discovery to clinic","volume":"188","author":"Agrawal","year":"2018","journal-title":"Pharmacol Ther"},{"key":"R23-20250812","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1615\/CritRevOncog.2015012997","article-title":"Histone deacetylases and mechanisms of regulation of gene expression","volume":"20","author":"Chen","year":"2015","journal-title":"Crit Rev Oncog"},{"key":"R24-20250812","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.104.074195","article-title":"RETRACTION: 5-aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45-and p53-dependent mechanisms","volume":"312","author":"Schneider-Stock","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R25-20250812","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3892\/ol.2016.4551","article-title":"Delineating the effect of demethylating agent 5-aza-2\u2032-deoxycytidine on human Caco-2 colonic carcinoma cells","volume":"12","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"R26-20250812","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/1541-7786.MCR-14-0054","article-title":"Prognostic potential of DNA methylation and transcript levels of HIF1A and EPAS1 in colorectal cancer","volume":"12","author":"Raw\u0142uszko-Wieczorek","year":"2014","journal-title":"Mol Cancer Res"},{"key":"R27-20250812","first-page":"2855","article-title":"Anti-invasive effects and proapoptotic activity induction by the rexinoid IIF and valproic acid in combination on colon cancer cell lines","volume":"32","author":"Papi","year":"2012","journal-title":"Anticancer Res"},{"key":"R28-20250812","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/ijc.24158","article-title":"Valproic acid enhances bosutinib cytotoxicity in colon cancer cells","volume":"124","author":"Mologni","year":"2009","journal-title":"Int J Cancer"},{"key":"R29-20250812","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.leukres.2004.11.022","article-title":"Antileukemia activity of the combination of 5-aza-CdR with valproic acid","volume":"29","author":"Yang","year":"2005","journal-title":"Leukemia Res"},{"key":"R30-20250812","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1158\/0008-5472.CAN-06-0080","article-title":"Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms","volume":"66","author":"Gore","year":"2006","journal-title":"Cancer Res"},{"key":"R31-20250812","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1158\/1541-7786.MCR-05-0229","article-title":"Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1,-A2,-A3, and-A12 in human cancer cells","volume":"4","author":"Wischnewski","year":"2006","journal-title":"Mol Cancer Res"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_410_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:28:12Z","timestamp":1787837292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.IJPVM_410_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_410_19","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2019-10-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}